Clinical Trial Management

Efficient and data-driven feasibility assessments are essential to identifying potential challenges early and ensuring each clinical trial is strategically designed for success.

A leading cause of clinical trial delays is insufficient patient enrollment. To help mitigate this risk, Clinixir’s feasibility team engages directly with sponsors and sites—assessing investigator interest, patient availability, projected enrollment rates, and site capabilities. This insight enables smarter site selection, faster study start-up, and better-informed planning.

As part of our strategic feasibility services, we also collaborate with Key Opinion Leaders (KOLs) to provide early protocol insights and site recommendations. Their clinical expertise helps refine study design, ensure alignment with local practices, and strengthen investigator engagement from the outset.

Feasibility services are available as part of a full-service package or as a standalone, fee-based engagement. Investing in a professional feasibility study can significantly reduce trial risk, optimize resource allocation, and improve the likelihood of meeting enrollment targets.

Learn more about our KOL Consultation Service →

Selecting the right sites is a critical factor in the success of any clinical trial. With Clinixir’s extensive network of clinical research centers across Thailand, we help sponsors identify and engage the most suitable sites based on protocol requirements, therapeutic focus, and target population.

Our site selection strategy enhances capacity and expertise, improves patient access, and ensures alignment with trial timelines. By leveraging relationships with top-performing hospitals, academic centers, and investigators, we enable sponsors to benefit from faster start-up, better enrollment, and cutting-edge clinical infrastructure.

See More our Partnership Sites →

Clinixir facilitates the critical start-up phase of clinical trials in Thailand—laying the groundwork for smooth execution and regulatory compliance from day one.

Our dedicated Study Start-Up (SSU) team handles all activities related to site readiness and regulatory submissions, including preparation and coordination of essential documents for Thailand’s FDA, as well as central and local ethics committees (EC/IRB). We ensure that every step aligns with both national regulations and international Good Clinical Practice (GCP) standards.

Each study is assigned an experienced SSU specialist who works closely with investigators and site staff to streamline approvals, reduce delays, and maintain submission accuracy. Our strong familiarity with Thailand’s regulatory landscape allows us to anticipate common bottlenecks and respond proactively—helping your study launch on time and stay on track.

With Clinixir’s start-up services, sponsors benefit from faster site activation, greater regulatory confidence, and seamless coordination with local stakeholders.

Effective project management is one of the most critical success factors in clinical research. Clinixir provides dedicated project managers who serve as the driving force behind each trial—ensuring that timelines are met, budgets are controlled, risks are minimized, and every deliverable aligns with regulatory and protocol expectations.

See More About Project Management →

Oncology trials are among the most complex and resource-intensive in clinical research. Clinixir supports sponsors with full-service project management, access to leading cancer centers, and collaboration with top-tier oncologists across Thailand. Our ability to navigate evolving regulatory requirements and manage long-term, data-heavy studies ensures trials are conducted with precision and compliance.

Thailand faces a growing burden of metabolic disorders, making it an ideal environment for studying treatments for conditions such as diabetes, obesity, and NASH. Clinixir works closely with experienced investigators and urban hospital networks to deliver trials that reflect local disease prevalence. We bring proven strategies for protocol adaptation, lifestyle-related variable management, and data-driven decision-making.

With its tropical climate and diverse patient population, Thailand is well-positioned for infectious disease research, including dengue, COVID-19, hepatitis, and tuberculosis. Clinixir leverages strong public-private site partnerships and a responsive regulatory framework to support fast-start trials and high-volume enrollment. Our local insight is key in managing outbreak-related studies and public health-focused research.

As a region rich in traditional medicine, Thailand offers unique opportunities for evidence-based research on herbal and botanical therapies. Clinixir provides expertise in designing studies that meet international standards while respecting local practices. We work closely with academic institutions and regulatory bodies to ensure product safety, consistency, and scientific validity throughout the research process.

Conducting rare disease trials requires specialized recruitment strategies and high coordination across stakeholders. Clinixir helps sponsors overcome challenges in patient identification and retention by leveraging Thailand’s academic networks and referral systems. We also support early engagement with regulatory authorities to streamline study approvals and orphan drug considerations.

Device trials require tailored protocols, usability evaluations, and precise regulatory alignment. Clinixir supports both diagnostic and therapeutic device studies, from feasibility through post-marketing. Our familiarity with Thailand’s Medical Device Control Division and hands-on experience managing combination product trials allows us to guide sponsors through compliant and efficient development.

Neurological research demands careful site selection, complex endpoint monitoring, and long-term follow-up. Clinixir supports trials in Alzheimer’s, Parkinson’s, epilepsy, and neurodevelopmental disorders, with access to leading neurologists and specialist centers. We focus on ensuring data quality and patient continuity throughout lengthy trial durations, while maintaining adherence to global best practices.

Clinixir actively supports clinical trials in advanced and evolving therapeutic areas, including cell and gene therapies such as CAR-T cell therapy. These studies demand complex regulatory navigation, specialized site coordination, and high standards of operational execution—all areas where our team delivers with confidence.

We remain open and responsive to supporting sponsors working in innovative or highly specialized fields beyond traditional trial models. With strong institutional partnerships, experienced project teams, and a flexible operational framework, Clinixir is well-positioned to adapt to new study designs and cutting-edge therapies as they emerge.

As the clinical research landscape evolves, we continue to expand our capabilities to meet the future of medicine.